Lumature Wealth Partners’s Gilead Sciences GILD Stock Holding History

Lumature Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29.4K	Buy	382 +15	+4%	+$1.2K	0.02%	250
2023 Q1	$30.4K	Sell	367 -10	-3%	-$828	0.02%	247
2022 Q4	$32.4K	Hold	377	–	–	0.02%	244
2022 Q3	$23K	Sell	377 -41	-10%	-$2.58K	0.01%	273
2022 Q2	$26K	Sell	418 -268	-39%	-$16.6K	0.01%	274
2022 Q1	$41K	Sell	686 -26	-4%	-$1.66K	0.02%	268
2021 Q4	$52K	Sell	712 -19	-3%	-$1.31K	0.02%	227
2021 Q3	$51K	Buy	731 +7	+1%	+$492	0.02%	231
2021 Q2	$50K	Sell	724 -61	-8%	-$4.07K	0.02%	231
2021 Q1	$51K	Buy	+785	New	+$50.6K	0.03%	230

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lumature Wealth Partners's GILD Position: Q2 2023 in Review

Lumature Wealth Partners increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2023, buying an estimated $1.2K and bringing the position to 382 shares worth $29.4K. The position accounts for 0.02% of the portfolio, ranked #250.

Lumature Wealth Partners first reported a position in GILD in Q1 2021 and has held it in 10 quarters since. The position peaked at $52K in Q4 2021. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

Lumature Wealth Partners held 382 shares of Gilead Sciences worth $29.4K as of Q2 2023.
Lumature Wealth Partners bought 15 Gilead Sciences shares in Q2 2023, an estimated $1.2K.
Gilead Sciences made up 0.02% of Lumature Wealth Partners's portfolio in Q2 2023, its #250 holding.
Lumature Wealth Partners first reported a position in Gilead Sciences in Q1 2021 and has held it in 10 quarters since.
Lumature Wealth Partners's Gilead Sciences position peaked at $52K in Q4 2021.
1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.